1159 related articles for article (PubMed ID: 7542604)
1. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
[TBL] [Abstract][Full Text] [Related]
2. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway.
McLellan AD; Sorg RV; Williams LA; Hart DN
Eur J Immunol; 1996 Jun; 26(6):1204-10. PubMed ID: 8647193
[TBL] [Abstract][Full Text] [Related]
3. B70 antigen is a second ligand for CTLA-4 and CD28.
Azuma M; Ito D; Yagita H; Okumura K; Phillips JH; Lanier LL; Somoza C
Nature; 1993 Nov; 366(6450):76-9. PubMed ID: 7694153
[TBL] [Abstract][Full Text] [Related]
4. ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells.
Witsch EJ; Peiser M; Hutloff A; Büchner K; Dorner BG; Jonuleit H; Mages HW; Kroczek RA
Eur J Immunol; 2002 Sep; 32(9):2680-6. PubMed ID: 12207353
[TBL] [Abstract][Full Text] [Related]
5. Expression of a hypoglycosylated form of CD86 (B7-2) on human T cells with altered binding properties to CD28 and CTLA-4.
Höllsberg P; Scholz C; Anderson DE; Greenfield EA; Kuchroo VK; Freeman GJ; Hafler DA
J Immunol; 1997 Nov; 159(10):4799-805. PubMed ID: 9366404
[TBL] [Abstract][Full Text] [Related]
6. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
[TBL] [Abstract][Full Text] [Related]
7. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL.
Lanier LL; O'Fallon S; Somoza C; Phillips JH; Linsley PS; Okumura K; Ito D; Azuma M
J Immunol; 1995 Jan; 154(1):97-105. PubMed ID: 7527824
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells.
Manzotti CN; Tipping H; Perry LC; Mead KI; Blair PJ; Zheng Y; Sansom DM
Eur J Immunol; 2002 Oct; 32(10):2888-96. PubMed ID: 12355442
[TBL] [Abstract][Full Text] [Related]
9. Interactions of CD80 and CD86 with CD28 and CTLA4.
Ellis JH; Burden MN; Vinogradov DV; Linge C; Crowe JS
J Immunol; 1996 Apr; 156(8):2700-9. PubMed ID: 8609386
[TBL] [Abstract][Full Text] [Related]
10. CD69, HLA-DR and the IL-2R identify persistently activated T cells in psoriasis vulgaris lesional skin: blood and skin comparisons by flow cytometry.
Ferenczi K; Burack L; Pope M; Krueger JG; Austin LM
J Autoimmun; 2000 Feb; 14(1):63-78. PubMed ID: 10648117
[TBL] [Abstract][Full Text] [Related]
11. Embryonic stem cells and embryoid bodies express lymphocyte costimulatory molecules.
Ling V; Munroe RC; Murphy EA; Gray GS
Exp Cell Res; 1998 May; 241(1):55-65. PubMed ID: 9633513
[TBL] [Abstract][Full Text] [Related]
12. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses.
Roy M; Aruffo A; Ledbetter J; Linsley P; Kehry M; Noelle R
Eur J Immunol; 1995 Feb; 25(2):596-603. PubMed ID: 7533092
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production.
Freeman GJ; Lombard DB; Gimmi CD; Brod SA; Lee K; Laning JC; Hafler DA; Dorf ME; Gray GS; Reiser H
J Immunol; 1992 Dec; 149(12):3795-801. PubMed ID: 1281186
[TBL] [Abstract][Full Text] [Related]
14. NK cell triggering by the human costimulatory molecules CD80 and CD86.
Wilson JL; Charo J; Martín-Fontecha A; Dellabona P; Casorati G; Chambers BJ; Kiessling R; Bejarano MT; Ljunggren HG
J Immunol; 1999 Oct; 163(8):4207-12. PubMed ID: 10510357
[TBL] [Abstract][Full Text] [Related]
15. T-cell regulation by CD28 and CTLA-4.
Alegre ML; Frauwirth KA; Thompson CB
Nat Rev Immunol; 2001 Dec; 1(3):220-8. PubMed ID: 11905831
[TBL] [Abstract][Full Text] [Related]
16. Role of CD80, CD86, and CTLA4 on mouse CD4(+) T lymphocytes in enhancing cell-cycle progression and survival after activation with PMA and ionomycin.
Mukherjee S; Maiti PK; Nandi D
J Leukoc Biol; 2002 Nov; 72(5):921-31. PubMed ID: 12429713
[TBL] [Abstract][Full Text] [Related]
17. The role of CD28-B7 costimulation in allergen-induced cytokine release by bronchial mucosa from patients with moderately severe asthma.
Lordan JL; Davies DE; Wilson SJ; Dent G; Corkhill A; Jaffar Z; Roberts K; Djukanović R; Holgate ST
J Allergy Clin Immunol; 2001 Dec; 108(6):976-81. PubMed ID: 11742276
[TBL] [Abstract][Full Text] [Related]
18. CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice.
Mathur M; Herrmann K; Qin Y; Gulmen F; Li X; Krimins R; Weinstock J; Elliott D; Bluestone JA; Padrid P
Am J Respir Cell Mol Biol; 1999 Oct; 21(4):498-509. PubMed ID: 10502560
[TBL] [Abstract][Full Text] [Related]
19. Functional differentiation of dendritic cells in rheumatoid arthritis: role of CD86 in the synovium.
Thomas R; Quinn C
J Immunol; 1996 Apr; 156(8):3074-86. PubMed ID: 8609431
[TBL] [Abstract][Full Text] [Related]
20. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
